Early nucleus basalis of Meynert degeneration predicts cognitive decline in Parkinson's disease

Brain. 2018 Jan 1;141(1):7-10. doi: 10.1093/brain/awx333.

Abstract

This scientific commentary refers to ‘In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson’s disease’ by Ray et al. (doi:10.1093/brain/awx310).

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Alzheimer Disease*
  • Atrophy
  • Basal Forebrain*
  • Basal Nucleus of Meynert
  • Cholinergic Agents
  • Cognitive Dysfunction*
  • Humans
  • Parkinson Disease*

Substances

  • Cholinergic Agents